We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

First-In-Human Study of Apramycin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04105205
Recruitment Status : Completed
First Posted : September 26, 2019
Last Update Posted : February 23, 2021
Innovative Medicines Initiative
Information provided by (Responsible Party):
Juvabis AG